Gregg Brandyberry Former Vice President of Procurement at GlaxoSmithKline GSK Joins Bioz Strategic Advisory Board
LOS ALTOS, Calif. - Feb. 19, 2019 (10:00 pm PT)
Bioz, Inc., a Silicon Valley A.I. data company, that has developed the world’s first and most comprehensive A.I. search engine for scientific experimentation, today announced an expansion of its Advisory Board, with the addition of Gregg Brandyberry, a procurement leader from the pharmaceutical industry.
Gregg Brandyberry is a recognized pioneer in procurement and sourcing technology, and the former Vice President of Procurement at GlaxoSmithKline (GSK), a fortune 150 company in the pharmaceuticals industry. Gregg has over 40 years of experience in healthcare, laboratory procurement, supply chain, quality, manufacturing, IT systems, operations, having held senior management roles in each discipline.
"I am excited to have Gregg on our Strategic Advisory Board. Gregg is very experienced in the biopharma and e-procurement space, and a big believer in the Bioz mission of surfacing objective product data from within millions of published scientific articles, to empower scientists to make smarter decisions when performing life science R&D," said Dr. Karin Lachmi, co-founder and Chief Scientific Officer of Bioz.
"It is great to have the opportunity to leverage Gregg's 40+ years of experience in biopharma procurement," said Daniel Levitt, CEO of Bioz. "As an evidence-based A.I. software company, Bioz brings objectivity and efficiency to life science discovery in the biopharma industry. With Gregg's significant experience and extensive network within biopharma, Bioz will accelerate the deployment of its technology into biopharma and e-procurement workflows," added Daniel.
"I'm proud to join the Bioz Strategic Advisory Board to advance biopharma procurement and life science discovery. Bioz is solving a real problem that R&D scientists in biopharma face daily, and is perfectly positioned to disrupt the status quo of inefficiency," said Gregg Brandyberry. "The Bioz research platform offers scientists an extensive array of efficiency-creating features to accelerate their important work, while bringing cost-savings to the biopharma procurement process," added Gregg.
Helpful Links
Suggested Tweet:@bioz_inc announces the addition of A.I. expert, Prof. Alon Halevy, to its Advisory Board https://bit.ly/2Ihb3Ej
About Bioz, Inc.
Bioz is the world's most advanced A.I. search engine for life science experimentation, empowering scientists in biopharma and academia to accelerate their research towards new discoveries. Bioz guides scientists to the most-validated and cost-effective products to use in their experiments by providing them with evidence-based product recommendations. These recommendations have been reverse-engineered from real-world experiments, as described in over 500 million pages of scientific text from peer-reviewed articles. The result: Bioz.com, the world's most comprehensive source of life science product recommendations and experimentation guidance, covering over 300 million products, 50,000 suppliers, 12 million images, and over 5 billion protocol conditions and associated techniques, enabling researchers to work faster and more cost-effectively, generating more successful and impactful outcomes.
Bioz A.I. was developed by an experienced team of software engineers, led by A.I. experts from Microsoft and Google and Nobel Prize winners in chemistry. The technology incorporates proprietary cutting-edge NLP, ML, neural networks, deep learning, and domain-specific named-entity recognition, entity matching, and entity linking algorithms. What used to take scientists months, now takes them mere minutes with Bioz, 82x times faster than before. By accelerating the pace of experiments, Bioz is accelerating the pace of drug discovery by as much as 50%, which translates into billions of research dollars saved. With objectivity, transparency, and trustworthiness, Bioz empowers researchers in the top 25 biopharma companies, and in more than 12,000 academic institutions in 196 countries.
To learn more about the Bioz please visit bioz.com.
Media Contact:
Daniel Levitt
Bioz, Inc.
pr@bioz.com